Commentary on 'Forum: Use of antidepressants in children and adolescents'

Current Opinion in Psychiatry

Volumn 23, Issue 1, 2010, Pages 62-63

  Hebebrand, Johannes ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PLACEBO;

BRAIN METABOLISM; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; HUMAN; NONHUMAN; NOTE; PLACEBO EFFECT; PSYCHOTHERAPY; RELAPSE; SUICIDE; TREATMENT RESPONSE;

ADOLESCENT; CHILD; DEPRESSIVE DISORDER; HUMANS; META-ANALYSIS AS TOPIC; SEROTONIN UPTAKE INHIBITORS;

EID: 74349085573     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e328334bd2c     Document Type: Note

References (7)

1. Mayberg HS, Silva JA, Brannan SK, et al. The functional neuroanatomy of the placebo effect. Am J Psychiatry 2002; 159:728-737.
2. Andrews G. Placebo response in depression: bane of research, boon to therapy. Br J Psychiatry 2001; 178:192-194.
3. Kirsch I, Moore TJ, Scoboria A, et al. The emperor's new drugs: an analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration. Prevention and Treatment 2002; http://www.journals.apa.org/ prevention/volume5/pre0050023a.html
4. Kennard BD, Silva SG, Mayes TL, et al. Assessment of safety and longterm outcomes of initial treatment with placebo in TADS. Am J Psychiatry 2009; 166:337-344.
5. Emslie GJ, Kennard BD, Mayes TL, et al. Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry 2008; 165:459-467.
6. Schneck CD, Miklowitz DJ, Miyahara S, et al. The prospective course of rapidcycling bipolar disorder: findings from the STEP-BD. Am J Psychiatry 2008; 165:370-377.
7. Bylund DB, Reed AL. Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs? Neurochem Int 2007; 51:246-253.